NCT07153588

Brief Summary

Glaucoma is often called the "silent thief of vision" because it can slowly damage the optic nerve and cause permanent blindness if it is not found and treated early. Many people are not aware of glaucoma, its risk factors, or the importance of regular eye checkups. This study is being conducted at the Ophthalmology Outpatient Department of Mardan Medical Complex, a large tertiary care hospital in Pakistan. The aim is to find out how much patients know and understand about glaucoma, and what beliefs or misconceptions they may have. A total of 379 patients between the ages of 18 and 80 years will be asked to complete a simple questionnaire. The questions cover background information, eye history, knowledge about glaucoma, and attitudes toward screening and treatment. For patients who cannot read, trained staff will help them complete the questionnaire. The information from this study will help doctors and health policy makers design better educational programs, improve public awareness, and encourage early eye screening. This can reduce the risk of irreversible vision loss caused by glaucoma

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
379

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 28, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 25, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 4, 2025

Completed
Last Updated

September 4, 2025

Status Verified

August 1, 2025

Enrollment Period

1 month

First QC Date

August 25, 2025

Last Update Submit

August 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Level of Awareness about Glaucoma

    Proportion of participants who demonstrate correct perception of glaucoma, defined as identifying it as a disease associated with increased intraocular pressure and risk of irreversible vision loss.

    At the time of questionnaire completion (baseline, single visit)

Secondary Outcomes (1)

  • Perception of Glaucoma and Its Curability

    (Baseline, single visit)

Interventions

This study uses a structured, interviewer-assisted questionnaire as the main intervention. The questionnaire is designed to assess patients' awareness and perception of glaucoma. It includes four sections: Sociodemographic information (age, gender, education, occupation, residence, family history) Ocular history (diagnosis of glaucoma, history of eye disease, surgery, or previous eye checkups) Awareness of glaucoma (understanding of risk factors, symptoms, prevention, and treatment options) Perceptions and attitudes (beliefs about curability, reversibility of vision loss, and willingness for screening and education). For illiterate participants, trained research staff will administer the questionnaire verbally without influencing responses. The data collection method distinguishes this intervention from treatment-based studies, as it focuses on knowledge assessment and perception analysis rather than a medical or surgical procedure.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population includes adult patients aged 18 to 80 years who attend the Ophthalmology Outpatient Department (OPD) at Mardan Medical Complex, a tertiary care teaching hospital in Khyber Pakhtunkhwa, Pakistan. Both new and follow-up patients are included, regardless of whether they have glaucoma or another eye condition. Participants come from a variety of backgrounds, with many residing in rural areas and a large proportion having limited or no formal education. Patients with diagnosed glaucoma, those with other ocular problems such as cataract or refractive errors, and individuals with systemic conditions like diabetes or hypertension are all eligible. Patients unable to provide informed responses due to cognitive impairment, mental illness, ocular malignancy, or active ocular bleeding are excluded.

You may qualify if:

  • Adult patients between 18 and 80 years of age attending the Ophthalmology Outpatient Department (new or follow-up cases).
  • Patients with ocular conditions, including diagnosed glaucoma and other eye pathologies.

You may not qualify if:

  • Patients with cognitive impairment or mental illness that limits their ability to understand or respond to the questionnaire.
  • Patients with ocular malignancy or active ocular bleeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mardan Medical Comlex, Mardan

Mardan, KPK, 23200, Pakistan

Location

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

August 25, 2025

First Posted

September 4, 2025

Study Start

April 28, 2025

Primary Completion

June 5, 2025

Study Completion

June 5, 2025

Last Updated

September 4, 2025

Record last verified: 2025-08

Locations